254 related articles for article (PubMed ID: 33777337)
21. De novo missense variants disrupting protein-protein interactions affect risk for autism through gene co-expression and protein networks in neuronal cell types.
Chen S; Wang J; Cicek E; Roeder K; Yu H; Devlin B
Mol Autism; 2020 Oct; 11(1):76. PubMed ID: 33032641
[TBL] [Abstract][Full Text] [Related]
22.
Alonso-Gonzalez A; Rodriguez-Fontenla C; Carracedo A
Front Genet; 2018; 9():406. PubMed ID: 30298087
[TBL] [Abstract][Full Text] [Related]
23. Targeted sequencing and integrative analysis of 3,195 Chinese patients with neurodevelopmental disorders prioritized 26 novel candidate genes.
Wang T; Zhang Y; Liu L; Wang Y; Chen H; Fan T; Li J; Xia K; Sun Z
J Genet Genomics; 2021 Apr; 48(4):312-323. PubMed ID: 33994118
[TBL] [Abstract][Full Text] [Related]
24. Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples.
Kosmicki JA; Samocha KE; Howrigan DP; Sanders SJ; Slowikowski K; Lek M; Karczewski KJ; Cutler DJ; Devlin B; Roeder K; Buxbaum JD; Neale BM; MacArthur DG; Wall DP; Robinson EB; Daly MJ
Nat Genet; 2017 Apr; 49(4):504-510. PubMed ID: 28191890
[TBL] [Abstract][Full Text] [Related]
25. Non-coding de novo mutations in chromatin interactions are implicated in autism spectrum disorder.
Kim IB; Lee T; Lee J; Kim J; Lee S; Koh IG; Kim JH; An JY; Lee H; Kim WK; Ju YS; Cho Y; Yu SJ; Kim SA; Oh M; Han DW; Kim E; Choi JK; Yoo HJ; Lee JH
Mol Psychiatry; 2022 Nov; 27(11):4680-4694. PubMed ID: 35840799
[TBL] [Abstract][Full Text] [Related]
26. De novo mutations in moderate or severe intellectual disability.
Hamdan FF; Srour M; Capo-Chichi JM; Daoud H; Nassif C; Patry L; Massicotte C; Ambalavanan A; Spiegelman D; Diallo O; Henrion E; Dionne-Laporte A; Fougerat A; Pshezhetsky AV; Venkateswaran S; Rouleau GA; Michaud JL
PLoS Genet; 2014 Oct; 10(10):e1004772. PubMed ID: 25356899
[TBL] [Abstract][Full Text] [Related]
27. Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability.
Hamdan FF; Gauthier J; Araki Y; Lin DT; Yoshizawa Y; Higashi K; Park AR; Spiegelman D; Dobrzeniecka S; Piton A; Tomitori H; Daoud H; Massicotte C; Henrion E; Diallo O; ; Shekarabi M; Marineau C; Shevell M; Maranda B; Mitchell G; Nadeau A; D'Anjou G; Vanasse M; Srour M; Lafrenière RG; Drapeau P; Lacaille JC; Kim E; Lee JR; Igarashi K; Huganir RL; Rouleau GA; Michaud JL
Am J Hum Genet; 2011 Mar; 88(3):306-16. PubMed ID: 21376300
[TBL] [Abstract][Full Text] [Related]
28. mirDNMR: a gene-centered database of background de novo mutation rates in human.
Jiang Y; Li Z; Liu Z; Chen D; Wu W; Du Y; Ji L; Jin ZB; Li W; Wu J
Nucleic Acids Res; 2017 Jan; 45(D1):D796-D803. PubMed ID: 27799474
[TBL] [Abstract][Full Text] [Related]
29. Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model.
Guo H; Wang T; Wu H; Long M; Coe BP; Li H; Xun G; Ou J; Chen B; Duan G; Bai T; Zhao N; Shen Y; Li Y; Wang Y; Zhang Y; Baker C; Liu Y; Pang N; Huang L; Han L; Jia X; Liu C; Ni H; Yang X; Xia L; Chen J; Shen L; Li Y; Zhao R; Zhao W; Peng J; Pan Q; Long Z; Su W; Tan J; Du X; Ke X; Yao M; Hu Z; Zou X; Zhao J; Bernier RA; Eichler EE; Xia K
Mol Autism; 2018; 9():64. PubMed ID: 30564305
[TBL] [Abstract][Full Text] [Related]
30. Genetic evidence of gender difference in autism spectrum disorder supports the female-protective effect.
Zhang Y; Li N; Li C; Zhang Z; Teng H; Wang Y; Zhao T; Shi L; Zhang K; Xia K; Li J; Sun Z
Transl Psychiatry; 2020 Jan; 10(1):4. PubMed ID: 32066658
[TBL] [Abstract][Full Text] [Related]
31. Targeted massively parallel sequencing of autism spectrum disorder-associated genes in a case control cohort reveals rare loss-of-function risk variants.
Griswold AJ; Dueker ND; Van Booven D; Rantus JA; Jaworski JM; Slifer SH; Schmidt MA; Hulme W; Konidari I; Whitehead PL; Cuccaro ML; Martin ER; Haines JL; Gilbert JR; Hussman JP; Pericak-Vance MA
Mol Autism; 2015; 6():43. PubMed ID: 26185613
[TBL] [Abstract][Full Text] [Related]
32. mTADA is a framework for identifying risk genes from de novo mutations in multiple traits.
Nguyen TH; Dobbyn A; Brown RC; Riley BP; Buxbaum JD; Pinto D; Purcell SM; Sullivan PF; He X; Stahl EA
Nat Commun; 2020 Jun; 11(1):2929. PubMed ID: 32522981
[TBL] [Abstract][Full Text] [Related]
33. [Study of
Gao ZJ; Jiang Q; Chen XL; Chen Q; Ji XN; Mao YY; Feng S; Dong JJ; Xu KM
Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(42):3426-3432. PubMed ID: 30440138
[No Abstract] [Full Text] [Related]
34. Implications of de novo mutations in guiding drug discovery: A study of four neuropsychiatric disorders.
So HC; Wong YH
J Psychiatr Res; 2019 Mar; 110():83-92. PubMed ID: 30597425
[TBL] [Abstract][Full Text] [Related]
35.
Wang Q; Liu Z; Lin Z; Zhang R; Lu Y; Su W; Li F; Xu X; Tu M; Lou Y; Zhao J; Zheng X
Front Genet; 2019; 10():605. PubMed ID: 31354784
[TBL] [Abstract][Full Text] [Related]
36. Varying Intolerance of Gene Pathways to Mutational Classes Explain Genetic Convergence across Neuropsychiatric Disorders.
Shohat S; Ben-David E; Shifman S
Cell Rep; 2017 Feb; 18(9):2217-2227. PubMed ID: 28249166
[TBL] [Abstract][Full Text] [Related]
37. Noncoding de novo mutations in
Zhang Y; Ahsan MU; Wang K
medRxiv; 2024 May; ():. PubMed ID: 38766206
[TBL] [Abstract][Full Text] [Related]
38. Genotype and phenotype correlations for SHANK3 de novo mutations in neurodevelopmental disorders.
Li Y; Jia X; Wu H; Xun G; Ou J; Zhang Q; Li H; Bai T; Hu Z; Zou X; Xia K; Guo H
Am J Med Genet A; 2018 Dec; 176(12):2668-2676. PubMed ID: 30537371
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and architecture of de novo mutations in developmental disorders.
Deciphering Developmental Disorders Study
Nature; 2017 Feb; 542(7642):433-438. PubMed ID: 28135719
[TBL] [Abstract][Full Text] [Related]
40. Integrative modeling of transmitted and
Li M; Zeng X; Jin C; Jin SC; Dong W; Brueckner M; Lifton R; Lu Q; Zhao H
Quant Biol; 2021 Jun; 9(2):216-227. PubMed ID: 35414959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
